CD163 and colorectal carcinoma: Patients with CRC (Swiss cohort) tumors with VEGFA gene amplification have reduced CD68+ and CD163+ TAM infiltration, while high-grade tumors are associated with increased CD163+ and reduced CD68+ macrophage infiltration (55).